Trial Profile
Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2023
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary) ; Prednisone (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 30 Apr 2021 Planned End Date changed from 1 Aug 2021 to 1 Aug 2023.
- 30 Apr 2021 Planned primary completion date changed from 1 Aug 2020 to 1 Aug 2022.
- 04 Jun 2019 Trial design presented at the 55th Annual Meeting of the American Society of Clinical Oncology